We found a similar frequency of OVA-specific CD8+ T-cells in mice treated with or without Rapa at the peak of CD8+ T-cell responses 7 days post-infection, but a decreased contraction of the CD8+ T-cell response in the Rapa-treated group when compared to the untreated group (Figure 1A). This evidence concerns the gene TRERF1 and infection.